Literature DB >> 26857232

The effects of culture conditions on the functionality of efficiently obtained mesenchymal stromal cells from human cord blood.

Anita Laitinen1, Milla Lampinen2, Stefanie Liedtke3, Lotta Kilpinen4, Erja Kerkelä4, Jertta-Riina Sarkanen5, Tuula Heinonen6, Gesine Kogler3, Saara Laitinen7.   

Abstract

BACKGROUND AIMS: Cord blood (CB) is an attractive source of mesenchymal stromal cells (MSCs) because of its abundant availability and ease of collection. However, the success rate of generating CB-MSCs is low. In this study, our aim was to demonstrate the efficiency of our previously described method to obtain MSCs from CB and further characterize them and to study the effects of different culture conditions on MSCs.
METHODS: CB-MSC cultures were established in low oxygen (3%) conditions on fibronectin in 10% fetal bovine serum containing culture medium supplemented with combinations of growth factors. Cells were characterized for their adipogenic, osteogenic and chondrogenic differentiation capacity; phenotype; and HOX gene expression profile. The functionality of the cells cultured in different media was tested in vitro with angiogenesis and T-cell proliferation assays.
RESULTS: We demonstrate 87% efficacy in generating MSCs from CB. The established cells had typical MSC characteristics with reduced adipogenic differentiation potential and a unique HOX gene fingerprint. Growth factor-rich medium and a 3% oxygen condition enhanced cell proliferation; however, the growth factor-rich medium had a negative effect on the expression of CD90. Dexamethasone-containing medium improved the capacity of the cells to suppress T-cell proliferation, whereas the cells grown without dexamethasone were more able to support angiogenesis.
CONCLUSIONS: Our results demonstrate that the composition of expansion medium is critical for the functionality of MSCs and should always be appropriately defined for each purpose.
Copyright © 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD90; angiogenesis; cord blood; immunosuppression; low oxygen; mesenchymal stromal cell

Mesh:

Substances:

Year:  2016        PMID: 26857232     DOI: 10.1016/j.jcyt.2015.11.014

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  3 in total

1.  Impact of procedural variability and study design quality on the efficacy of cell-based therapies for heart failure - a meta-analysis.

Authors:  Zhiyi Xu; Sebastian Neuber; Timo Nazari-Shafti; Zihou Liu; Fengquan Dong; Christof Stamm
Journal:  PLoS One       Date:  2022-01-05       Impact factor: 3.240

2.  Generation of mesenchymal stromal cells from cord blood: evaluation of in vitro quality parameters prior to clinical use.

Authors:  Eliana Amati; Sabrina Sella; Omar Perbellini; Alberta Alghisi; Martina Bernardi; Katia Chieregato; Chiara Lievore; Denise Peserico; Manuela Rigno; Anna Zilio; Marco Ruggeri; Francesco Rodeghiero; Giuseppe Astori
Journal:  Stem Cell Res Ther       Date:  2017-01-24       Impact factor: 6.832

3.  Mesenchymal Stromal Cells Cultured in Serum from Heart Failure Patients Are More Resistant to Simulated Chronic and Acute Stress.

Authors:  Timo Z Nazari-Shafti; Zhiyi Xu; Andreas Matthäus Bader; Georg Henke; Kristin Klose; Volkmar Falk; Christof Stamm
Journal:  Stem Cells Int       Date:  2018-04-01       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.